NPRA approves six-month shelf life extension for Coronavac, Comirnaty Covid-19 vaccines

PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved an extension for the shelf life of SinoVac's CoronaVac and Pfizer-BioNTech's Comirnaty Covid-19 vaccines, says Health director-general Tan Sri Dr Noor Hisham Abdullah.

He said NPRA had approved the respective applications from Pharmaniaga Lifescience Sdn Bhd and Pfizer (Malaysia) Sdn Bhd.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Expiry date , Shelf life , SinoVac , CoronaVac , Pfizer , BioNTech , Comirnaty , Covid-19 , Vaccine , Health Ministry , Noor Hisham Abdullah

Next In Nation
Johor fast gaining traction as medical tourism destination
Asean success raised the bar
Nga: Housing Ministry to implement�10 priority initiatives
Ah long threats leave family afraid to go home
Not easy feeding kids nowadays
Online safety can’t be done ‘in one shot’
Selangor has highest bankruptcy rate nationwide
Ancestral home�in Kelantan on the brink of collapse
MACC confirms corporate probe
Young voters torn between Barisan and Warisan

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.